How to carefully sell a non-core activity — while creating both calmness and value
-
Tristan Arkesteijn - August 17, 2026
- A well-performing business unit can still no longer fit strategically. In that case, a sale may be the logical choice, but a carve-out is rarely simple.
- Especially in healthcare, systems, contracts, employees and responsibilities are often deeply intertwined with the wider organisation.
- For a specialised healthcare institution, we managed the entire process: from separation and a standalone proposition to due diligence and negotiations.
- The result: a successful sale to the right buyer, with continuity for patients, employees and partners.
Sometimes the strategic choice is simple: an activity no longer fits the core of the organisation.
Execution is usually less simple.
That was also the case for a specialised healthcare institution with its own institutional pharmacy. The activity was performing well, but no longer fitted the organisation’s future positioning. Not in terms of focus, scale or its strategic role in the broader healthcare landscape.
A sale was therefore the logical choice.
But how do you sell a business unit that is still fully intertwined with the rest of the organisation operationally?
Separate first, sell second
The pharmacy relied on systems, processes and contracts that were closely connected to the parent organisation.
Think of:
- employee deployment and HR structures;
- healthcare contracts and supply agreements;
- IT systems, reimbursement processes and compliance;
- links with primary care processes.
There was another factor: the activity was regulated. Continuity for patients and employees was therefore not a nice-to-have, but a hard requirement.
Tristan Arkesteijn of Het Strategiekantoor managed the entire process, from the strategic assessment through to the sale.
The first step was to get a number of key questions clear:
- What is the service area?
- What does the customer structure look like, and how stable is it?
- Which contracts, obligations and risks are relevant?
- How dependent is the unit on the parent organisation?
- And which legal, financial and operational structure is required for it to operate independently?
A buyer does not want to buy a puzzle
Based on this analysis, the carve-out plan was developed.
We created a standalone financial proposition and an operational blueprint showing how the business unit could function independently. We also prepared the information memorandum and investor profile, as well as the due diligence process: data room, Q&A process and risk file.
The negotiations with interested buyers were also managed.
Throughout the process, we worked closely with finance, legal advisers, healthcare purchasers and the primary care operation.
The challenge was to do two things at the same time: organise the separation carefully internally while keeping the sales process as lean and understandable as possible for bidders.
After all, a buyer does not want to spend weeks reconstructing how a business unit works.
Staying calm in the process creates value
Within a few months, there was a robust sales dossier in place.
Employees knew where they stood. Supply-chain partners and health insurers were involved in good time. And interested buyers were able to arrive at a well-founded bid quickly.
The outcome:
- a carefully structured sale that was operationally executable from day one;
- continuity of care and contractual obligations without interruption;
- support within the organisation and among external stakeholders;
- and a buyer that fitted the people, the vision and the stage the business unit was in.
The healthcare institution could then once again focus fully on its core task. The divested unit found a new home, with room for further growth.
For us, it does not stop after the PowerPoint
A carve-out is not a strategy project that ends with a recommendation. The analysis matters. But ultimately, the value lies in execution: separating, structuring, aligning, negotiating and making sure the deal actually works. That is where Het Strategiekantoor’s way of working fits well. No handover once things become complicated. No layers of overhead. No loss of knowledge between strategy and execution. You work with the same compact, experienced team from start to finish, all the way through to closing the deal.
The strategic rigour of a top-tier firm, combined with the agility and pragmatism that a complex carve-out requires.
Read more:
-
Our take on things
Surf’s up, PE: The green home installation wave is finally here.
Read morePrivate equity has long spotted opportunities in the construction sector. Positively, the need for sustainable housing is a safe bet for growth, so companies concepting and making ground-up greener housing have been hoovered up. But there’s a complementary trend — and significant PE opportunity — that’s still overlooked: green home installation companies. A quick breakdown highlights volume and potential: - €33.5 billion: 2022 revenue of the Dutch construction market’s housing segment (new build, renovation, maintenance) - €2.4 billion (7% of total): 2022 revenue of the Dutch sustainable home installation market - 1.7% CAGR 2022-2026 expected for the sustainable home installation market, driven by renovation demand (and despite lower new-build housing volumes) For PEs with construction companies in their portfolio, investing in green installation firms is a straightforward route to broader presence in sustainable housing value chains. In parallel, both new and existing builds (will) need green installations. Well-placed investment will cover both these housing types, across the social and private sectors. In short, this market’s in need of a new breed of investor: ready to take calculated risks, for high rewards. As a seasoned insider, I’m convinced of the green home installation sector’s potential for strong social and financial returns. -
Our take on things
How to grow as a specialised healthcare provider — without losing focus
Read moreTop clinical care requires focus. But it also requires reach. For a specialised healthcare provider with nationwide ambitions, this created a strategic question: how do you increase patient inflow to the main location without creating fragmentation or compromising quality? The solution was sought in a satellite model: regional locations for pre- and aftercare, while complex treatment remains concentrated at one central location. Sounds logical. But where do you establish such a satellite? And who do you partner with? -
Our take on things
Is generative AI the end of strategy consulting?
Read moreLet’s be frank: strategy consulting is a prime target for overhaul with generative artificial intelligence (GenAI). Change is coming — it just remains to be seen in exactly what form: Will AI make the profession obsolete?Can companies rely on AI alone to tackle the challenges currently entrusted to consulting firms, eliminating human expertise?Or will this heavyweight industry, steadily growing for decades, adapt to an AI-driven landscape? If yes, what will value-for-money strategy consulting look like? And what should strategy consultants — and our clients — be doing now to intelligently ride the GenAI wave?